While our studies focused largely on inhibiting CCKAR-mediated contraction, the absence of effect of CCKAR antagonists on BAL cell differential counts or inflammatory cytokines nevertheless suggests that blocking CCKAR-mediated ASM contraction is sufficient to suppress obesity-associated AHR. Here, CCKAR is linked to obesity disorder.